Mercer Global Advisors Inc Pfizer Inc Transaction History

Mercer Global Advisors Inc

$35.2 Billion
Q1 2024

A detailed history of Mercer Global Advisors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 891,771 shares of PFE stock, worth $25 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

891,771

Previous 985,523 9.51%

Holding current value

$25 Million

Previous $28.4 Million 12.73%

% of portfolio

0.07%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $2.43 Million - $2.79 Million	-93,752 Reduced 9.51%	891,771 $24.8 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $2 Million - $2.59 Million	-76,414 Reduced 7.2%	985,523 $28.4 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $1.06 Million - $1.24 Million	-33,042 Reduced 3.02%	1,061,937 $35.2 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $2.97 Million - $3.44 Million	82,217 Added 8.12%	1,094,979 $40.2 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $307,084 - $399,778	7,796 Added 0.78%	1,012,762 $41.3 Million

Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $2.96 Million - $3.87 Million	70,920 Added 7.59%	1,004,966 $51.5 Million
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $2.12 Million - $2.59 Million	48,444 Added 5.47%	934,046 $40.9 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $3.86 Million - $4.57 Million	82,900 Added 10.33%	885,602 $46.4 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $2.55 Million - $3.16 Million	55,816 Added 7.47%	802,702 $41.6 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $4.26 Million - $6.32 Million	103,188 Added 16.03%	746,886 $44.1 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $1.65 Million - $2.12 Million	42,015 Added 6.98%	643,698 $27.7 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $1.15 Million - $1.3 Million	31,910 Added 5.6%	601,683 $23.6 Million
Q1 2021 Aug 10, 2021	BUY	$33.49 - $37.77 $273,378 - $308,316	8,163 Added 1.45%	569,773 $20.6 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $248,897 - $280,706	-7,432 Reduced 1.31%	561,610 $20.3 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $693,063 - $881,289	20,707 Added 3.78%	569,042 $20.9 Million
Q3 2020 Dec 10, 2020	BUY	$31.75 - $37.25 $33,655 - $39,485	1,060 Added 0.19%	548,335 $20.1 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $623,032 - $755,829	20,685 Added 3.93%	547,275 $17.9 Million
Q1 2020 May 18, 2020	SELL	$27.03 - $38.62 $458,320 - $654,840	-16,956 Reduced 3.12%	526,590 $17.2 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $3.22 Million - $3.65 Million	97,820 Added 21.95%	543,546 $21.3 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $2.9 Million - $3.77 Million	89,396 Added 25.09%	445,726 $16 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $1.97 Million - $2.21 Million	53,233 Added 17.56%	356,330 $15.4 Million
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $169,387 - $186,100	-4,517 Reduced 1.47%	303,097 $12.9 Million
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $11.5 Million - $12.7 Million	307,614 New	307,614 $13.4 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Pfizer Inc Transaction History